ZombieHealthcare
What Happened to Abpro Holdings?
Ticker: ABPOSPAC Year: 2022
Return
-98.7%
Current Price
$0.13
Peak Price
$390
Trust Size
$2M
Summary
Abpro Holdings is a biotechnology company developing next-generation multispecific antibody therapeutics for oncology and ophthalmology indications.
What Happened
Abpro went public through a SPAC merger and trades under ABPO. The company is developing bispecific and multispecific antibodies for cancer treatment and eye diseases. As a pre-revenue biotech, the stock has declined significantly with a reverse stock split executed, and the company faces typical early-stage biotech funding challenges.
Timeline
2022-01-06
S-1 Registration Filed
Risk Indicators
⚠️ Reverse Split